Neurontin and Embeda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neurontin (gabapentin) and Embeda (morphine sulfate; naltrexone hydrochloride). Common drug interactions include sinusitis among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Neurontin and Embeda. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

What is Embeda?

Embeda has active ingredients of morphine sulfate; naltrexone hydrochloride. eHealthMe is studying from 1,407 Embeda users. Check the latest studies of Embeda.



On Jul, 10, 2026

46 people who take Neurontin and Embeda together, and have interactions are studied.

Neurontin and Embeda drug interactions.

What are the common drug interactions of Neurontin and Embeda, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Upper respiratory tract infection
  3. Weight decreased
  4. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  5. Drug hypersensitivity
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Somnambulism (sleep walking)
  10. Dyskinesia (abnormality or impairment of voluntary movement)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Arthralgia (joint pain)
  3. Pain in extremity
  4. Adverse drug reaction
  5. Agitation (state of anxiety or nervous excitement)
  6. Anger
  7. Completed suicide (act of taking one's own life)
  8. Mood swings (an extreme or rapid change in mood)
  9. Pruritus (severe itching of the skin)
  10. Rash

What are the common drug interactions of Neurontin and Embeda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Adverse drug reaction
  2. Completed suicide (act of taking one's own life)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypotension (abnormally low blood pressure)

30-39:

  1. Migraine (headache)
  2. Fatigue (feeling of tiredness)
  3. Influenza like illness
  4. Pyrexia (fever)

40-49:

  1. Drug ineffective
  2. Proctalgia (pain in the rectum)
  3. Drug effect decreased
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Abdominal pain
  6. Arthropathy
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  9. Diarrhoea
  10. Fatigue (feeling of tiredness)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Arthralgia (joint pain)
  3. Chills (felling of cold)
  4. Decreased appetite
  5. Fatigue (feeling of tiredness)
  6. Feeling cold
  7. Feeling hot
  8. Hyperhidrosis (abnormally increased sweating)
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Lethargy (tiredness)

60+:

  1. Drug hypersensitivity
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Personality change
  6. Post-traumatic stress disorder
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Social avoidant behaviour (avoiding social connection a personality disorder)
  9. Somnambulism (sleep walking)
  10. Visual impairment

What are the existing conditions these people have? *

  1. Pain: 10 people, 21.74%
  2. Neuropathy Peripheral (surface nerve damage): 9 people, 19.57%
  3. High Blood Pressure: 9 people, 19.57%
  4. Back Pain: 8 people, 17.39%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 15.22%
  6. Stress And Anxiety: 6 people, 13.04%
  7. Immunodeficiency Common Variable: 6 people, 13.04%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 13.04%
  9. High Blood Cholesterol: 5 people, 10.87%
  10. Indigestion: 4 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and Embeda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neurontin and Embeda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Embeda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neurontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Embeda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and morphine sulfate; naltrexone hydrochloride (the active ingredients of Neurontin and Embeda, respectively), and Neurontin and Embeda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: